US FDA Expanded Access Pilot Launching Soon With Staffing Questions Unanswered

Related Content

Expanded Access Program Improving, But Sponsor Concerns Linger

Sarepta Tells Patients To Stand Down, Golodirsen Future 'Our Responsibility'

When Expanded Access Also Means Off-Label Use, US FDA May Need New Policy

Gottlieb: Lack Of Compromise On Right-To-Try Bill Is 'Interesting Lesson In Politics' For Stakeholders

‘Project Facilitate’: US FDA Plans May Meeting On Expanded Access Call Center

Expanded Access: US FDA Told To Increase Regulatory Clarity, Early Interactions With Sponsors

Expanded Access Data Supported Lutathera Approval, US FDA Notes

Reagan-Udall Expanded Access Navigator Ready To Launch

FDA's Compassionate Use Initiatives: Web Clearinghouse, Guidance Documents

FDA Crisis Management: Behind-The-Scenes Of Josh Hardy's Compassionate Use